Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

• Motasim Badri ,

  *To whom correspondence should be addressed. E-mail: motasim.badri@hiv-research.org.za

  Affiliation Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

  ⨯
• Gary Maartens,

  Affiliation Department of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa

  ⨯
• Sundhiya Mandalia,

  Affiliations NPMS-HHC Coordination and Analytic Centre, Chelsea and Westminster Hospital, London, United Kingdom, Department of Medicine, Imperial College, Chelsea and Westminster Hospital, London, United Kingdom

  ⨯
• Linda-Gail Bekker,

  Affiliation Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

  ⨯
• John R Penrod,

  Affiliation Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada

  ⨯
• Robert W Platt,

  Affiliation Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

  ⨯
• Robin Wood ,

  Contributed equally to this work with: Robin Wood, Eduard J Beck

  Affiliation Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

  ⨯
• Eduard J Beck

  Contributed equally to this work with: Robin Wood, Eduard J Beck

  Affiliations NPMS-HHC Coordination and Analytic Centre, Chelsea and Westminster Hospital, London, United Kingdom, Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

  ⨯